Ads
related to: tacrolimus- 109 S High St #100, Columbus, OH · Directions · (614) 224-4261
singlecare.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Tacrolimus, sold under the brand name Prograf among others, is an immunosuppressive drug. After allogenic organ transplant , the risk of organ rejection is moderate. To lower the risk of organ rejection, tacrolimus is given.
mTOR inhibitors are a class of drugs used to treat several human diseases, including cancer, autoimmune diseases, and neurodegeneration. They function by inhibiting the mammalian target of rapamycin (mTOR) (also known as the mechanistic target of rapamycin), which is a serine/threonine-specific protein kinase that belongs to the family of phosphatidylinositol-3 kinase (PI3K) related kinases ...
Tacrolimus (trade names Prograf, Astagraf XL, Envarsus XR) is a product of the bacterium Streptomyces tsukubensis. It is a macrolide lactone and acts by inhibiting calcineurin. The drug is used primarily in liver and kidney transplantations, although in some clinics it is used in heart, lung, and heart/lung transplantations.
Tacrolimus has been found to reduce episodes of organ rejection over a related treatment, the drug ciclosporin, which binds cyclophilin. [4] [5] Both the FKBP-tacrolimus complex and the cyclosporin-cyclophilin complex inhibit a phosphatase called calcineurin, thus blocking signal transduction in the T-lymphocyte transduction pathway. [6]
LCP-Tacro (tacrolimus) is a once-daily dosage version of tacrolimus for prevention of rejection in organ transplant patients in two Phase 3 clinical trials in kidney transplant patients. The first study in stable transplant patients showed that LCP-Tacro was non-inferior in efficacy and safety compared to twice-daily tacrolimus (Prograf ...
Ascomycin, also called Immunomycin, FR-900520, FK520, is an ethyl analog of tacrolimus (FK506) with strong immunosuppressant properties. It has been researched for the treatment of autoimmune diseases and skin diseases, and to prevent rejection after an organ transplant.
Common immunosuppressive drugs linked to gingival hyperplasia are cyclosporin and tacrolimus. [1] The most frequently used immunosuppressive drug is cyclosporin, which is commonly prescribed after an organ transplant. Nearly 53% of patients taking cyclosporin after renal transplants presented with gingival growth. [1]
Tohru Kino (木野 亨, Kino Tōru) is a Japanese chemist and pharmacologist, best known for his discovery of tacrolimus.. While working for Fujisawa Pharmaceutical Company in the 1980s (Astellas Pharma today), Kino and his colleagues found that FK-506 (now called tacrolimus), which is produced by the soil bacterium Streptomyces tsukubaensisis, could be expected to be an immunosuppressive drug.
Ads
related to: tacrolimus- 109 S High St #100, Columbus, OH · Directions · (614) 224-4261
singlecare.com has been visited by 100K+ users in the past month